Coverage
-
September 17, 2014
The makers of several glucosamine-based supplements have agreed to pay $3.1 million to settle a proposed class action in California federal court accusing them of misleading consumers about the products' supposed joint health benefits despite myriad scientific evidence disputing those claims.
1 other articles on this case.
View all »